跳至主要内容
临床试验/NCT01798862
NCT01798862已完成2 期

The Effect of Endometrial Injury on IVF Outcome Parameters in Patients With Repeated Implantation Failures

National and Kapodistrian University of Athens2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
2
主要终点
positive bHCG rate

研究概览

简要总结

The iatrogenic induction of local endometrial injury caused through hysteroscopy or pipelle sampling in the preceding non- transfer cycle improves the IVF outcome parameters in patients with previous IVF failures.

详细描述

Endometrial injury was preformed either through hysteroscope during office hysteroscopy through the non touch technique or through pipelle biopsy in the early follicular phase (days 5 to 9) in the preceding cycle of the IVF treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •* Personal history of 2 or more failed IVF/ICSI cycles (RIF)
  • •* Age\2)

排除标准

  • •Personal history of endometrial tuberculosis/ antituberculous treatment
  • •Sonographically detected hydrosalpinges
  • •Intramural fibroids distorting the endometrial cavity, submucous myomas or Asherman's syndrome
  • •Thrombophilia

研究组 & 干预措施

Endometrial injury by hysteroscopy or pipelle sapling

Experimental

Endometrial Sampling by pipelle or hysteroscopy performed once between 6th to 10th day in the cycle prior to the fresh IVF/ ICSI cycle.

干预措施: Endometrial injury by hysteroscopy or pipelle sampling (Procedure)

COH for IVF without hysteroscopy or pipelle sampling

Active Comparator

Procedure: COH for IVF Both GnRH agonists (long, starting at day 2 or 21) with triptorelin acetate 0.1 mg (Gonapeptyl daily) and antagonists with ganirelix 0.25mg (Orgalutran) or cetrorelix 0.25mg (Cetrotide) protocols will be used; for ovarian stimulation both recombinant FSH ( Puregon) and human menopausal gonadotrophin ( Menopur) will be used. Ovarian response will be monitored by ultrasonography, oocyte retrieval will be performed 36-38 hours after the Hcg triggering and for luteal phase support 600 mg progesterone tablets ( Utrogestan) will be applied.

干预措施: Proceed to COH directly (Procedure)

结局指标

主要结局

positive bHCG rate

时间窗: through study completion, an average of 2 years

次要结局

  • Pregnancy complications (preterm birth, placental abnormalities, bleeding throughout pregnancy, pregnancy related hypertensive disorders, IUGR and SGA)(2 years)
  • live birth rate(2 years)
  • clinical pregnancy rate(2 years)
  • Ectopic pregnancy rate(2 years)
  • Miscarriage rate(2 years)
  • Ongoing pregnancy rate(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Siristatidis Charalampos, MD, PhD

Assistant Professor in Obstetrics and Gynecology / Assisted Reproduction

National and Kapodistrian University of Athens

研究点 (2)

Loading locations...

相似试验